Effect of pannexin channel inhibitor or P2R antagonist on the expression of MUC5AC in poly(I:C)-treated differentiated human bronchial epithelial cells from COPD patients. This evidence concerns the gene MUC5AC and chronic obstructive pulmonary disease.